Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln
22/04/2016 12:00
April 22 (Reuters) - Parnell Pharmaceuticals Holdings Ltd
PARN.O
* Q1 revenue rose 43 percent to $2.2 million
* Parnell pharmaceuticals holdings ltd announces first
quarter business update
* Reiterate 2016 revenue guidance
Source text for Eikon: ID:nGNXMQNZYa
Further company coverage: PARN.O
((Bengaluru Newsroom) ((+1 646 223 8780;)))
Recent news on Parnell Pharmaceuticals Holdings
See all newsBrief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln